3 insights to kick-start your day, featuring PharmEasy’s fundraise

Rights time In the news. Troubled health-tech company PharmEasy will go ahead with a rights issue to raise funding, which is likely to commence in the first week of August. Inside the news. The company could take a massive 90% cut from the USD5.6 billion valuation from its last funding round. However, as per sources, the board is yet to finalise the pricing of the shares. Sources added that PharmEasy received an offer from Manipal Group